Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KNSA | CGON | APLS | ||
| Company | Kiniksa Pharmaceuticals International Plc | Cg Oncology Inc | Apellis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 42.48 | 39.83 | 25.08 | ||
| High | 42.58 | 40.47 | 25.08 | ||
| Low | 41.65 | 39.47 | 24.58 | ||
| Latest | 42.00 | 39.84 | 24.97 | ||
| Change | -0.49 | -0.30 | -0.19 | ||
| % Change | -1.15% | -0.75% | -0.76% | ||
| Volume | 199,900 | 561,900 | 786,600 | ||
| 20-Day Average Volume | 395,105 | 830,450 | 2,288,145 | ||
| Previous Close | 42.49 | 40.14 | 25.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.64 | 41.05 | 23.86 | ||
| 20-Day Raw Stochastic | 49.69% | 31.44% | 79.50% | ||
| 20-Day Relative Strength | 55.44 | 47.73 | 57.11 | ||
| Weighted Alpha | +95.94 | +56.27 | -6.44 | ||
| Today's Opinion | 100% Buy | 40% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/18/25 | +4.84% since 12/18/25 | +2.00% since 12/18/25 | ||
| Low | 41.65 on 12/26/25 | 37.73 on 12/19/25 | 24.36 on 12/19/25 | ||
| High | 44.42 on 12/22/25 | 40.95 on 12/22/25 | 26.12 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | -1.27% since 11/26/25 | -11.15% since 11/26/25 | +15.66% since 11/26/25 | ||
| Low | 39.61 on 12/03/25 | 37.01 on 12/17/25 | 20.51 on 12/02/25 | ||
| High | 44.42 on 12/22/25 | 46.01 on 12/05/25 | 26.12 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | +15.10% since 09/26/25 | +6.13% since 09/26/25 | +11.62% since 09/26/25 | ||
| Low | 35.20 on 10/28/25 | 35.80 on 11/11/25 | 18.75 on 11/07/25 | ||
| High | 44.42 on 12/22/25 | 46.01 on 12/05/25 | 30.48 on 10/28/25 | ||
| 6-Month | |||||
| %Chg | +47.42% since 06/26/25 | +52.82% since 06/26/25 | +35.71% since 06/26/25 | ||
| Low | 26.27 on 07/25/25 | 23.65 on 08/11/25 | 17.15 on 06/30/25 | ||
| High | 44.42 on 12/22/25 | 46.01 on 12/05/25 | 30.48 on 10/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,183,432 | 3,213,734 | 3,159,329 | ||
| Shares Outstanding, K | 75,796 | 80,666 | 126,525 | ||
| Annual Sales | 423,240,000 | 1,140,000 | 781,370,000 | ||
| Annual Net Income | -43,190,000 | -88,040,000 | -197,880,000 | ||
| Last Quarter Sales | 180,860,000 | 1,670,000 | 458,580,000 | ||
| Last Quarter Net Income | 18,440,000 | -43,810,000 | 215,720,000 | ||
| 60-Month Beta | 0.02 | 1.29 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.23 on 10/28/25 | -0.57 on 11/14/25 | 1.67 on 10/30/25 | ||
| Latest Earnings Date | 02/24/26 | 03/27/26 | 02/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 94.42 | 0.00 | 81.16 | ||